KELOWNA, BC / ACCESSWIRE / January 20, 2016 / Lexaria Corp. (OTCQB:LXRP) (CSE:LXX) (the “Firm”) could be very happy to announce research knowledge from human topics demonstrating vital elevation of systemic nitric oxide ranges as a surrogate biomarker for cannabidiol (CBD) bioabsorption in response to ingestion of Lexaria’s merchandise.

As beforehand introduced, the research was undertaken to offer medical help for the CBD bioavailability enhancing properties of Lexaria’s patent-pending know-how, on the premise that bioavailable CBD is understood to raise ranges of the endocannabinoid anandamide within the human physique which, in flip, stimulates launch of nitric oxide within the vascular system.

Abstract: consuming Lexaria and ViPova meals merchandise resulted in elevated ranges of nitric oxide inside the physique. The outcomes of the research indicated that each one Lexaria and ViPova meals merchandise elicited vital will increase in salivary nitric oxide, attaining ranges from 110 µM to as excessive as 220 µM...